Keyphrases
Hepatocellular Carcinoma
100%
Genetic Polymorphism
96%
Ethanol
85%
Pre-microRNA
64%
Hepatic Ischemia-reperfusion Injury
64%
Interleukin-17 (IL-17)
64%
Radiofrequency Ablation
64%
Pancreatic Fluid Collections
64%
Interleukin-6
64%
Odds Ratio
60%
Hepatitis C Virus
58%
GGsTop
53%
Confidence Interval
53%
Polymorphism
50%
Meta-analysis
48%
Rs2275913
45%
Alcoholic Liver Disease
45%
Necrosis
44%
Obesity
40%
High Mobility Group Box 1 (HMGB1)
39%
Therapeutic Effect
38%
Non-alcoholic Fatty Liver Disease (NAFLD)
37%
Glutamyl Transpeptidase
36%
Liver
35%
4-hydroxynonenal (4-HNE)
35%
5′-untranslated Region (5′-UTR)
34%
Ethanol Intake
34%
Japan
33%
Walled-off
33%
Cytochrome P450 2E1 (CYP2E1)
33%
Risk Factors
33%
Limy Bile
32%
Binge Drinking
32%
Simple Steatosis
32%
Image Fusion System
32%
SLC6A4
32%
MicroRNA-325
32%
Functional Dyspepsia
32%
NF1 Gene
32%
Colonic Cancer
32%
Aphthous Stomatitis
32%
Irsogladine Maleate
32%
Recurrent Aphthous Stomatitis
32%
Gastroduodenal Diseases
32%
IL-17F
32%
Nonalcoholic Steatohepatitis
32%
Oxidative Stress
32%
Diabetic Dyslipidemia
32%
Advanced Glycation End Products
32%
Ischemia-reperfusion Injury
32%
Pharmacology, Toxicology and Pharmaceutical Science
Gamma Glutamyltransferase
86%
Ischemia
77%
Nonalcoholic Fatty Liver
64%
Reperfusion Injury
64%
Liver Ischemia
64%
Ethanol
56%
Fatty Liver
55%
Alcohol Liver Disease
49%
Hepatitis C Virus
42%
Alcoholic Fatty Liver
38%
Steatosis
37%
Neoplasm
36%
Therapeutic Effect
35%
Liver Cell Carcinoma
35%
Otsuka Long Evans Tokushima Fatty Rat
35%
1,1 Dimethylhydrazine
32%
Irsogladine Maleate
32%
Aphthous Stomatitis
32%
Duodenum Disease
32%
Dyslipidemia
32%
Recombinant Thrombomodulin
32%
Diabetes Mellitus
32%
Chronic Hepatitis
32%
Osteopontin
32%
Peginterferon
32%
Jejunum Ulcer
32%
Hepatitis C
32%
Advanced Glycation End Product
32%
Delirium
32%
Pancreas Cancer
32%
Ribavirin
32%
Interleukin 6
32%
Liver Fibrosis
32%
Biological Marker
32%
Tissue Injury
32%
Interleukin 17
32%
Colon Carcinoma
32%
4 Hydroxynonenal
31%
Cytochrome
30%
Fibrosis
30%
Adverse Event
26%
Normal Human
18%
Liver Necrosis
11%
Tumor Necrosis Factor
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Acetylsalicylic Acid
10%
Pharmacotherapy
10%
Opiate
10%
Aspartate Aminotransferase
10%
Alanine Aminotransferase
10%
Medicine and Dentistry
Endoscopic Ultrasound
73%
Nonalcoholic Fatty Liver
64%
Hepatocellular Carcinoma
64%
Radiofrequency Ablation
64%
Necrosis
58%
Alcohol Liver Disease
49%
Steatosis
37%
Alcohol
35%
Alcoholic Fatty Liver
35%
Gamma-Glutamyl Transpeptidase
35%
Therapy Effect
34%
Odds Ratio
33%
Limy Bile
32%
Thrombocytosis
32%
Diabetes Mellitus
32%
Dyslipidemia
32%
Alcohol Consumption
32%
Oxidative Stress
32%
Pancreas Tumor
32%
Echography
32%
Mesothelioma
32%
Celiac Plexus
32%
Advanced Glycation End-Product
32%
Balloon Dilatation
32%
Pancreas Cancer
32%
Delirium
32%
Chronic Hepatitis
32%
Obstructive Jaundice
32%
Ischemia
32%
Tissue Injury
32%
Fatty Liver
32%
Interleukin 6
32%
Common Bile Duct
27%
4 Hydroxynonenal
26%
Neoplasm
21%
Cytochrome
21%
Common Bile Duct Stone
21%
Endoscopic Retrograde Cholangiopancreatography
21%
Adverse Event
19%
Randomized Controlled Trial
19%
Infection
18%
Acute Pancreatitis
18%
Gastrectomy
17%
Hepatocyte
16%
Systematic Review
16%
Fine-Needle Aspiration
16%
COVID-19
16%
Roux-en-Y
16%
Meta-Analysis
16%
Immunoglobulin G4 Related Disease
16%
